Bonum Therapeutics

Seattle, United States

Bonum Therapeutics creates a technology platform to treat a wide range of diseases.

Apr 2026

Venture - Series Unknown

Biotechnology Life Science Medical Therapeutics

Top Investors

Vivo CapitalDigitalis VenturesRiverVestCodon Capital3×5 Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bonum Therapeutics

Who are Bonum Therapeutics's investors?

Bonum Therapeutics's investors include Vivo Capital, Digitalis Ventures, RiverVest, Codon Capital, 3×5 Partners.

Where is Bonum Therapeutics headquartered?

Bonum Therapeutics is headquartered in Seattle, United States.

What does Bonum Therapeutics do?

Bonum Therapeutics creates a technology platform to treat a wide range of diseases.

What stage is Bonum Therapeutics at?

Bonum Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 17, 2026.

MLA

"Bonum Therapeutics — Funding & Investors." VCBacked, April 17, 2026, https://www.vcbacked.co/company/bonum-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2026). Bonum Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/bonum-therapeutics

Wikipedia (cite web)

{{cite web |title=Bonum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bonum-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 17, 2026.

Similar Companies in Biotechnology